EPX Limited Invites Shareholders to Join $700K Share Purchase Plan at $0.25

EPX Limited has launched a Share Purchase Plan offering eligible shareholders the chance to buy new shares at $0.25 each, matching a recent institutional placement price. The plan aims to raise up to $700,000 to support the company’s growth and working capital needs.

  • Share Purchase Plan open to eligible shareholders in select countries
  • Maximum subscription of $30,000 per shareholder at $0.25 per share
  • Plan aims to raise up to $700,000, non-underwritten and subject to scale back
  • Offer price aligns with recent $2.14 million institutional placement
  • Funds targeted for general working capital and growth initiatives
An image related to Epx Limited
Image source middle. ©

Context and Offer Details

EPX Limited has announced a Share Purchase Plan (SPP) designed to give its eligible shareholders an opportunity to increase their stake in the company at a fixed price of $0.25 per share. This price matches the recent institutional placement completed in mid-December 2025, which raised $2.14 million to fund strategic acquisitions, including the Wattwatchers transaction, and to support future technology investments.

The SPP opens on 29 December 2025 and closes on 20 January 2026, allowing shareholders recorded on the company’s register as of 17 December 2025 with addresses in Australia, New Zealand, Sri Lanka, the Netherlands, the United Kingdom, Singapore, or the United Arab Emirates to participate. Notably, shareholders in the United States are excluded due to regulatory restrictions.

Subscription Limits and Pricing

Each eligible shareholder can subscribe for up to $30,000 worth of new shares, with increments starting at $1,000. The issue price represents a 20% premium to the recent five-day volume weighted average price (VWAP) but a 22% discount to the 20-day VWAP, reflecting a balanced approach to pricing that rewards existing shareholders while maintaining market competitiveness.

The plan is not underwritten, and the company aims to raise up to $700,000. However, the board retains discretion to scale back applications or adjust the total amount raised depending on demand. This means shareholders may receive fewer shares than applied for if the plan is oversubscribed.

Strategic Implications and Shareholder Impact

Funds raised through the SPP will primarily support EPX’s general working capital requirements and growth initiatives, including potential mergers and acquisitions. By offering shares at the same price as the institutional placement, EPX signals its intent to treat retail shareholders equitably and foster broader participation in its growth story.

Shareholders are advised to carefully consider the speculative nature of the investment, as share prices may fluctuate between the offer and allotment dates. The company recommends consulting financial advisors before participating. The new shares will rank equally with existing shares, ensuring no preferential treatment in voting or dividends.

Next Steps for Shareholders

Eligible shareholders can apply via BPAY or electronic funds transfer, with detailed instructions provided in the SPP booklet accessible through the company’s investor portal. The company also offers support through its share registry for any queries. The allotment of new shares and their quotation on the ASX are expected on 23 January 2026, with shareholding statements dispatched the same day.

EPX’s approach to this capital raise reflects a cautious yet proactive stance, balancing the need for growth capital with shareholder value preservation. The coming weeks will reveal the level of retail investor appetite and the final capital raised under the plan.

Bottom Line?

EPX’s SPP offers shareholders a timely chance to deepen their investment, but the final capital raised will hinge on demand and potential scale backs.

Questions in the middle?

  • Will the SPP reach its $700,000 target or face significant scale back?
  • How will the market price of EPX shares react post-SPP allotment?
  • What are the company’s next strategic moves following the capital raise?